Evidence map›Paper›PMID 41591586›Full record

ReviewProbiotics and antimicrobial proteins2026

Probiotic and Microbial Enzymatic Mechanisms for PFAS Detoxification.

Md Rayhan Chowdhury, Ariful Islam, Valentina Yurina, Takeshi Shimosato

Abstract readReview
In one paragraph

Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Md Rayhan ChowdhuryGraduate School of Medicine, Science and Technology, Shinshu University, Minamiminowa, Nagano, 399-4598, Japan.
Ariful IslamDepartment of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Valentina YurinaDepartment of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia.
Takeshi ShimosatoInstitute for Aqua Regeneration, Shinshu University, Minamiminowa, Nagano, Kamiina, 399-4598, Japan. shimot@shinshu-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Per- and polyfluoroalkyl substances (PFAS) are highly persistent environmental contaminants that pose a significant threat to ecosystems and human health due to their exceptional chemical stability and resistance to degradation. Conventional remediation methods-such as activated carbon adsorption, ion exchange, and advanced oxidation-primarily transfer PFAS between phases rather than achieving complete mineralization, resulting in the generation of secondary waste. Microbial bioremediation has emerged as a promising, sustainable strategy. Several bacteria, fungi, and cyanobacteria can transform or defluorinate PFAS under environmentally relevant conditions, yielding less fluorinated intermediates. Enzymatic studies have identified oxygenases and reductive dehalogenases as key catalysts in the cleavage of C-F bonds. Moreover, recent evidence indicates that the gut microbiota can adsorb and sequester PFAS, facilitating fecal elimination and reducing systemic toxicity. Advances in synthetic biology now enable the engineering of microbial systems, including probiotic strains, with enhanced PFAS uptake and degradation capabilities. However, significant challenges remain; current microbial pathways primarily act through partial transformation rather than complete mineralization, often accumulating stable fluorinated intermediates. True mineralization is constrained by low enzymatic efficiency, narrow substrate specificity, and the difficulty of translating laboratory success to complex environmental matrices. This review critically synthesizes current progress in microbial and probiotic bioremediation of PFAS, emphasizing enzymatic mechanisms, microbial pathways, and integration with conventional treatment systems. By engaging with these limitations alongside promising advances, we provide a balanced assessment of the feasibility of microbial and engineered probiotic approaches, highlighting knowledge gaps and future directions for developing safe, scalable detoxification technologies.

Indexed as

BacteriaEnvironmental PollutantsFluorocarbonsFungiProbioticsBiodegradation, EnvironmentalHumansEnvironmental PollutantsFluorocarbonsEnvironmental detoxificationEnzymatic defluorinationGut microbiotaMicrobial bioremediationPFASProbioticsSynthetic biology

Identifiers

PMID41591586
PMCPMC13369350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.